Updated Jul 16, 2026
Schambye Hans T. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $17K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-06 | DMRA | Damora Therapeutics, Inc. | S — Open-market sale | 700 | $21.38 | $15K |
| 2026-01-06 | DMRA | Damora Therapeutics, Inc. | M — Option exercise | 1.4K | — | |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | S — Open-market sale | 735 | $3.38 | $2K |
| 2025-07-03 | DMRA | Damora Therapeutics, Inc. | M — Option exercise | 1.4K | — |
Schambye Hans T. is a corporate insider — currently tracked as Insider. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($17K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Schambye Hans T. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.